BlackRock Group’s HealthEquity HQY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$3.81M Buy
93,986
+46,353
+97% +$1.79M ﹤0.01% 1339
2016
Q3
$1.8M Buy
47,633
+8,625
+22% +$273K ﹤0.01% 1694
2016
Q2
$1.19M Buy
39,008
+7,263
+23% +$191K ﹤0.01% 1884
2016
Q1
$783K Buy
31,745
+3,689
+13% +$79.1K ﹤0.01% 2051
2015
Q4
$703K Buy
28,056
+952
+4% +$29.2K ﹤0.01% 2063
2015
Q3
$801K Buy
27,104
+288
+1% +$9.05K ﹤0.01% 2006
2015
Q2
$859K Buy
+26,816
New +$720K ﹤0.01% 2034
2014
Q4
Sell
-45,658
Closed -$835K 2889
2014
Q3
$835K Buy
+45,658
New +$877K ﹤0.01% 1890

Other funds holding HQY

BlackRock Group's HQY Position: Q4 2016 in Review

BlackRock Group increased its HealthEquity (HQY) stake by 97% in Q4 2016, buying an estimated $1.79M and bringing the position to 93,986 shares worth $3.81M. The position accounts for ﹤0.01% of the portfolio, ranked #1339.

BlackRock Group first reported a position in HQY in Q3 2014 and has held it in 8 quarters since. 200 funds tracked by Wall St. Rank hold HQY as of Q4 2016.

  • BlackRock Group held 93,986 shares of HealthEquity worth $3.81M as of Q4 2016.
  • BlackRock Group bought 46,353 HealthEquity shares in Q4 2016, an estimated $1.79M.
  • HealthEquity made up ﹤0.01% of BlackRock Group's portfolio in Q4 2016, its #1339 holding.
  • BlackRock Group first reported a position in HealthEquity in Q3 2014 and has held it in 8 quarters since.
  • 200 funds tracked by Wall St. Rank held HealthEquity as of Q4 2016.

Based on BlackRock Group's 13F filing for Q4 2016, filed 10 Feb 2017.